Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shujing Xu

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Plos Genetics|December 30, 2015
An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association StudiesWesley K Thompson, Yunpeng Wang, Andrew J Schork, et al.
Acta Pharmaceutica Sinica. B|September 6, 2021
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitorsShenghua Gao, Tianguang Huang, Letian Song, et al.
Bioorganic Chemistry|August 24, 2021
Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused librariesYucen Tao, Xia Hao, Lanlan Jing, et al.
European Journal of Medicinal Chemistry|May 31, 2022
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural featuresShenghua Gao, Yusen Cheng, Shu Song, et al.
Environment International|November 21, 2019
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approachRan Jin, Rob McConnell, Cioffi Catherine, et al.
Bioorganic & Medicinal Chemistry|December 10, 2021
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitorsShujing Xu, Shu Song, Lin Sun, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Nature|July 31, 2024
Transport and inhibition mechanisms of the human noradrenaline transporterTuo Hu, Zhuoya Yu, Jun Zhao, et al.
Journal of Medicinal Chemistry|July 13, 2026
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug ResistanceMei Wang, Zeyu Peng, Yang Zhou, et al.
Journal of Medical Virology|April 5, 2024
Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stabilityXiangyi Jiang, Zhen Gao, Prem Prakash Sharma, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Plos Genetics|December 30, 2015
An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association StudiesWesley K Thompson, Yunpeng Wang, Andrew J Schork, et al.
Acta Pharmaceutica Sinica. B|September 6, 2021
Medicinal chemistry strategies towards the development of effective SARS-CoV-2 inhibitorsShenghua Gao, Tianguang Huang, Letian Song, et al.
Bioorganic Chemistry|August 24, 2021
Discovery of potent and selective Cdc25 phosphatase inhibitors via rapid assembly and in situ screening of Quinonoid-focused librariesYucen Tao, Xia Hao, Lanlan Jing, et al.
European Journal of Medicinal Chemistry|May 31, 2022
Chemical space exploration around indolylarylsulfone scaffold led to a novel class of highly active HIV-1 NNRTIs with spiro structural featuresShenghua Gao, Yusen Cheng, Shu Song, et al.
Environment International|November 21, 2019
Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approachRan Jin, Rob McConnell, Cioffi Catherine, et al.
Bioorganic & Medicinal Chemistry|December 10, 2021
Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitorsShujing Xu, Shu Song, Lin Sun, et al.
Molecules (Basel, Switzerland)|November 11, 2022
Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid ModulatorsXujie Zhang, Lin Sun, Shujing Xu, et al.
Nature|July 31, 2024
Transport and inhibition mechanisms of the human noradrenaline transporterTuo Hu, Zhuoya Yu, Jun Zhao, et al.
Journal of Medicinal Chemistry|July 13, 2026
Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug ResistanceMei Wang, Zeyu Peng, Yang Zhou, et al.
Journal of Medical Virology|April 5, 2024
Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stabilityXiangyi Jiang, Zhen Gao, Prem Prakash Sharma, et al.
Pageof 11